Andreas Mock

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Beyond attention heatmaps: How to get better explanations for multiple instance learning models in histopathology.

Beyond attention heatmaps: How to get better explanations for multiple instance learning models in histopathology.

Journal: Medical image analysis

Published: February 26, 2026

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma.

Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma.

Journal: EMBO molecular medicine

Published: January 06, 2026

Antinuclear antibody (ANA) level and blood-profile in Oral lichen planus patients: A cross-sectional study.

Antinuclear antibody (ANA) level and blood-profile in Oral lichen planus patients: A cross-sectional study.

Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery

Published: November 23, 2025

Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients.

Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients.

Journal: NPJ precision oncology

Published: November 19, 2025

Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas.

Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas.

Journal: NPJ precision oncology

Published: October 10, 2025

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Journal: Med (New York, N.Y.)

Published: July 27, 2025

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials.

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trials.

Journal: NPJ precision oncology

Published: May 14, 2025

Neural interaction explainable AI predicts drug response across cancers.

Neural interaction explainable AI predicts drug response across cancers.

Journal: NAR cancer

Published: February 26, 2025

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Journal: Nature communications

Published: February 25, 2025

Deep Learning for Biomarker Discovery in Cancer Genomes.

Deep Learning for Biomarker Discovery in Cancer Genomes.

Journal: bioRxiv : the preprint server for biology

Published: January 20, 2025

First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis.

First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis.

Journal: Journal of cancer research and clinical oncology

Published: December 23, 2024

Showing 1-12 of 73

Last Updated: 09/26/2026